Published on in Vol 11, No 1 (2022): Jan-Jun
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/32234, first published
.
Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
Journals
- Ceolin G, Breda V, Koning E, Meyyappan A, Gomes F, Moreira J, Gerchman F, Brietzke E. A Possible Antidepressive Effect of Dietary Interventions: Emergent Findings and Research Challenges. Current Treatment Options in Psychiatry 2022;9(3):151 View
- Teixeira A, Martins L, Berk M, Bauer M. Severe psychiatric disorders and general medical comorbidities: inflammation-related mechanisms and therapeutic opportunities. Clinical Science 2022;136(17):1257 View
- Liu L, Wang H, Chen X, Xie P. Gut microbiota: a new insight into neurological diseases. Chinese Medical Journal 2023;136(11):1261 View
- MacKay M, Yang B, Dursun S, Baker G. The Gut-Brain Axis and the Microbiome in Anxiety Disorders, Post-Traumatic Stress Disorder and Obsessive-Compulsive Disorder. Current Neuropharmacology 2024;22(5):866 View
- Khaledi M, Sameni F, Gholipour A, Shahrjerdi S, Golmohammadi R, Gouvarchin Ghaleh H, Poureslamfar B, Hemmati J, Mobarezpour N, Milasi Y, Rad F, Mehboodi M, Owlia P. Potential role of gut microbiota in major depressive disorder: A review. Heliyon 2024;10(12):e33157 View